XML 77 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation Plans (Schedule Of Total Stock Option, Stock Award And PSU Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Options, Granted 298,670 287,010 246,350
Weighted Average Grant-Date Price, Granted $ 466.43 $ 331.69 $ 333.75
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Options, Outstanding at January 1, 2020 1,205,948    
Number of Options, Granted 298,670    
Number of Options, Exercised/Vested (419,145)    
Number of Options, Canceled/Forfeited (15,402)    
Number of Options, Outstanding at December 31, 2020 1,070,071 1,205,948  
Number of Options, Vested and expected to vest at December 31, 2020 1,070,071    
Number of Options, Exercisable at December 31, 2020 510,938    
Weighted Average Exercise Price, Outstanding at January 1, 2020 $ 252.77    
Weighted Average Exercise Price, Granted 471.74    
Weighted Average Exercise Price, Exercised/Vested 176.73    
Weighted Average Exercise Price, Canceled/Forfeited 369.84    
Weighted Average Exercise Price, Outstanding at December 31, 2020 341.99 $ 252.77  
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020 341.99    
Weighted Average Exercise Price, Exercisable at December 31, 2020 $ 246.03    
Weighted Average Remaining Contractual Life (Years), Outstanding at December 31, 2020 3 years 6 months    
Weighted Average Remaining Contractual Life (Years), Vested and expected to vest at December 31, 2020 3 years 6 months    
Weighted Average Remaining Contractual Life (Years), Exercisable at December 31, 2020 2 years 8 months 12 days    
Aggregate Intrinsic Value, Outstanding at December 31, 2020 $ 198,910    
Aggregate Intrinsic Value, Vested and dxpected to vest at December 31, 2020 198,910    
Aggregate Intrinsic Value, Exercisable at December 31, 2020 $ 144,003    
Stock Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Awards, Outstanding at January 1, 2020    
Number of Awards, Granted 2,511    
Number of Awards, Exercised/Vested (2,511)    
Number of Awards, Canceled/ Forfeited    
Number of Awards, Outstanding at December 31, 2020  
Number of Awards, Vested and expected to vest at December 31, 2020    
Weighted Average Grant-Date Price, Outstanding at January 1, 2020    
Weighted Average Grant-Date Price, Granted 466.43    
Weighted Average Grant-Date Price, Exercised/Vested 466.34    
Weighted Average Grant-Date Price, Canceled/Forfeited    
Weighted Average Grant-Date Price, Outstanding at December 31, 2020  
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020 [1]    
Perfromance Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Nonvested Target Units, Outstanding at January 1, 2020 42,978    
Number of Nonvested Target Units, Granted 22,378    
Number of Nonvested Target Units, Exercised/Vested (26,454)    
Number of Nonvested Target Units, Canceled/Forfeited (706)    
Number of Nonvested Target Units, Outstanding at December 31, 2020 38,196 42,978  
Number of Nonvested Target Units, Vested and expected to vest at December 31, 2020 69,106    
Weighted Average Grant-Date Price, Outstanding at January 1, 2020 $ 288.78    
Weighted Average Grant-Date Price, Granted 365.12    
Weighted Average Grant-Date Price, Exercised/Vested 197.02    
Weighted Average Grant-Date Price, Canceled/Forfeited 472.68    
Weighted Average Grant-Date Price, Outstanding at December 31, 2020 396.93 $ 288.78  
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2020 [1] $ 386.33    
[1] Amount includes 26,525 share units which vested and were converted to shares of stock and distributed in the first quarter of 2021.